Product Overview
Cytarabine (also known as Ara-C) is known as a pyrimidine nucleoside analogue and is widely available as a chemotherapy agent.
As an API, it plays an important role in anti-cancer formulations. It’s made under strict GMP conditions.
This ensures high purity and stability for both injectable and oral formulations.
Therapeutic Applications
In Acute Myeloid Leukemia, it is the main drug for starting and maintaining treatment.
Utilised in the combination regimens for effective cell kill.
Helps to manage blast-phase disease progression.
Used intrathecally to control CNS Leukemia.
Helps to block DNA replication, slowing or stopping cancer cell growth.
Specification Parameters
-
Molecular Formula: C₉H₁₃N₃O₅
-
Molecular Weight: 243.22 g/mol
-
Melting Point: 212–217°C
-
Appearance: White to off-white crystalline powder
-
Heavy Metals: ≤ 10 ppm
-
Identification: IR/UV & HPLC retention time match
-
Purity (HPLC): ≥ 98.0%
Packaging & Storage
Cytarabine Active Pharmaceutical Ingredient (API) packaging involves a process to be done in secure containment, and this is in HDPE drums, for bulk powder (thereby protecting it from moisture).
Furthermore, protection is provided by inner liners (often double-bagged) and sealed drums that prevent moisture.
Why Choose Us
We offer ISO-certified facilities and ensure regulatory compliance and adherence to standards.
Offering high assay and low impurity levels, suitable for injectable-grade formulations.
Ensure timely delivery for both small and bulk requirements.
Cost-effective sourcing for formulations and distributors.
